CircRNA hsa_circ_001895 serves as a sponge of miR-296-5p to promote cell carcinoma progression via regulating SOX12.
It is an urgent need to find novel potential therapeutic targets for diagnosis and treatment of ccRCC (clear cell renal cell carcinoma ) due to its highly invasive ability as a common urological malignant tumor. CircRNAs (circular RNAs) have been indicated as potentially critical mediator in various tumor progression. We first demonstrated qRT-PCR analysis to find dysregulated circRNAs in ccRCC. A novel circRNA, hsa_circ_001895, was up-regulated in ccRCC specimens and associated with metastatic properties of ccRCC. However, the tumorigenic mechanism of hsa_circ_001895 on ccRCC is yet to be found. We first indicated that hsa_circ_001895 predicted a poor prognosis in ccRCC patients. Additionally, overexpression of hsa_circ_001895 not only promoted cell proliferation, invasion and migration of ccRCC, but also inhibited cell apoptosis, while hsa_circ_001895 knockdown reversed the effect on ccRCC progression. In vivo subcutaneous xenotransplanted tumor model also revealed that silence of hsa_circ_001895 could suppress in vivo ccRCC growth. Mechanistically, hsa_circ_001895 directly bind with miR-296-5p and inhibited its expression. Moreover, SRY (sex determining region Y)-box 12 (SOX12) was identified as targets of miR-296-5p, whose expression was suppressed by miR-296-5p. Notably, the inhibitory effect of hsa_circ_001895 on ccRCC progression was reversed by miR-296-5p inhibitor. In general, our findings indicated hsa_circ_001895 may sponge miR-296-5p and promote SOX12 expression, which is the underlying mechanism of hsa_circ_001895-induced ccRCC progression.